170 related articles for article (PubMed ID: 28876284)
1. In Vitro Synergy Testing of Gentamicin, an Old Drug Suggested as Future Treatment Option for Gonorrhoea, in Combination With Six Other Antimicrobials Against Multidrug-Resistant Neisseria gonorrhoeae Strains.
Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R
Sex Transm Dis; 2018 Feb; 45(2):127-131. PubMed ID: 28876284
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era.
Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R
PLoS One; 2018; 13(3):e0193678. PubMed ID: 29509792
[TBL] [Abstract][Full Text] [Related]
3.
Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X
Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731
[TBL] [Abstract][Full Text] [Related]
4. Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution.
Wind CM; de Vries HJ; van Dam AP
Int J Antimicrob Agents; 2015 Mar; 45(3):305-8. PubMed ID: 25532741
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy for gonorrhoea: in vitro synergy testing.
Pereira R; Cole MJ; Ison CA
J Antimicrob Chemother; 2013 Mar; 68(3):640-3. PubMed ID: 23152483
[TBL] [Abstract][Full Text] [Related]
6. In vitro potency and combination testing of antimicrobial agents against Neisseria gonorrhoeae.
Bharat A; Martin I; Zhanel GG; Mulvey MR
J Infect Chemother; 2016 Mar; 22(3):194-7. PubMed ID: 26603424
[TBL] [Abstract][Full Text] [Related]
7. In vitro assessment of gentamicin and azithromycin-based combination therapy against Neisseria gonorrhoeae isolates in India.
Sood S; Agarwal SK; Singh R; Gupta S; Sharma VK
J Med Microbiol; 2019 Apr; 68(4):555-559. PubMed ID: 30869583
[TBL] [Abstract][Full Text] [Related]
8. In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.
Barbee LA; Soge OO; Holmes KK; Golden MR
J Antimicrob Chemother; 2014 Jun; 69(6):1572-8. PubMed ID: 24468865
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of antimicrobial combinations against clinical isolates of Neisseria gonorrhoeae.
Furuya R; Koga Y; Irie S; Ikeda F; Kanayama A; Kobayashi I; Tanaka M
J Infect Chemother; 2013 Dec; 19(6):1218-20. PubMed ID: 23564350
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains.
Jacobsson S; Golparian D; Phan LT; Ohnishi M; Fredlund H; Or YS; Unemo M
J Antimicrob Chemother; 2015 Jan; 70(1):173-7. PubMed ID: 25182063
[TBL] [Abstract][Full Text] [Related]
11. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of tigecycline alone and antimicrobial combinations against clinical Neisseria gonorrhoeae isolates.
Lee H; Kim H; Seo YH; Yong D; Jeong SH; Lee K; Chong Y
Diagn Microbiol Infect Dis; 2017 Feb; 87(2):160-162. PubMed ID: 27890419
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae.
Allen GP; Deao KM; Hill SA; Schipelliti SM; Tran T
Int J Antimicrob Agents; 2021 Oct; 58(4):106417. PubMed ID: 34391903
[TBL] [Abstract][Full Text] [Related]
14. Gentamicin Susceptibility among a Sample of Multidrug-Resistant Neisseria gonorrhoeae Isolates in India.
Bala M; Singh V; Bhargava A; Kakran M; Joshi NC; Bhatnagar R
Antimicrob Agents Chemother; 2016 Dec; 60(12):7518-7521. PubMed ID: 27736753
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential.
Lagacé-Wiens PRS; Adam HJ; Laing NM; Baxter MR; Martin I; Mulvey MR; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2017 Aug; 72(8):2273-2277. PubMed ID: 28505331
[TBL] [Abstract][Full Text] [Related]
16. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
[TBL] [Abstract][Full Text] [Related]
17. Spectinomycin, gentamicin, and routine disc diffusion testing: An alternative for the treatment and monitoring of multidrug-resistant Neisseria gonorrhoeae?
Martins JM; Scheffer MC; de Melo Machado H; Schörner MA; Golfetto L; Santos TMD; Barazzetti FH; de Albuquerque VCB; Bazzo ML
J Microbiol Methods; 2022 Jun; 197():106480. PubMed ID: 35526670
[TBL] [Abstract][Full Text] [Related]
18. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
[TBL] [Abstract][Full Text] [Related]
19. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.
Unemo M
BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005
[TBL] [Abstract][Full Text] [Related]
20. Global resistance of Neisseria gonorrhoeae: when theory becomes reality.
Lewis DA
Curr Opin Infect Dis; 2014 Feb; 27(1):62-7. PubMed ID: 24275696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
